Better Therapeutic Index May Help Conquer Cell Division
By Anette Breindl
Tuesday, April 9, 2013
WASHINGTON As far as cellular processes go, mitosis seems like a natural target for cancer drugs. "Its major business is cell growth," Genentech Inc.'s Peter Jackson told the audience at the annual meeting of the American Association for Cancer Research (AACR). It's got kinases lots of kinases. And there is a "vast array" of traditional chemotherapies that hits some aspect of the cell cycle.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.